Restoring the balance with Regulatory T Cell Therapies
Quell Therapeutics is a London based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date:
18 January 2024, 12:00 (Thursday, 1st week, Hilary 2024)
Venue:
Seminar room
Speaker:
Luke Devey (Chief Medical Officer)
Organising department:
Department of Paediatrics
Organiser:
Sheena Lee (MSD Business Partnerships Office)
Booking required?:
Not required
Booking url:
https://forms.office.com/e/suZ1J5CiU1
Cost:
None
Audience:
Members of the University only
Editor:
Laura Borg
